Yüklüyor......
Sequential Treatment With Targeted and Immune Checkpoint Therapy in Patients With BRAF Positive Metastatic Melanoma: The Importance of Timing?
Background: Immune checkpoint- and targeted therapy have dramatically improved the therapeutic landscape in the management of BRAF mutation positive metastatic melanoma. However, pending the results of clinical trials, not only is it currently unclear whether immune checkpoint- or targeted therapy s...
Kaydedildi:
| Yayımlandı: | Front Med (Lausanne) |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6928141/ https://ncbi.nlm.nih.gov/pubmed/31921863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2019.00257 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|